Shenandoah Therapeutics

South San Francisco, CA · Founded 2022 · Privately Held (backing)

Developer of an oncology technology platform designed for cancer treatment. Shenandoah Therapeutics is based in South San Francisco, CA and was founded in 2022. Its last reported valuation was $37 million in Mar 2025. It has raised $21.5 million across 1 recorded round; the latest was a $21.5 million early-stage round in May 2025.

Last reported valuation
$37.0M
Oct 2026
Priced at
—
Total raised
$21.5M
Last round
Early Stage VC
May 2025

Who backs Shenandoah Therapeutics?

5 investors
InvestorType
Samsara BioCapitalVenture capital
Honghui CapitalVenture capital
First Spark VenturesVenture capital
Time BioVentures—
YK Bioventures—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Shenandoah Therapeutics investors

5 investors are on record for Shenandoah Therapeutics, including Samsara BioCapital, Honghui Capital, First Spark Ventures and Time BioVentures. The early-stage round in May 2025 drew 12 investors.

Private Market View
More of Shenandoah Therapeutics with a free Private Market View account
  • ·Watch Shenandoah Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 5 firms already write checks for companies like Shenandoah Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View